Yves Beuzard
7Patents
4h-index
19Co-inventors
54Inventor score
Filing activity: Nov 13, 1985 → Oct 9, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6464998B1 | Composition for the in vivo production of therapeutic products | Chemistry; Metallurgy | 23 | Expired |
| US5125264A | Device and apparatus for detecting and measuring by echography particles settling in a fluid | Physics | 13 | Expired |
| US6331557A | Use of divalent cations for inhibiting erythrocyte dehydration in vivo | Human Necessities | 9 | Expired |
| US4694015A | Pharmaceutical or veterinary compositions containing thiosulfonate derivatives | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4696937A | Thiosulfonate derivatives for inhibiting malformation or destruction of red blood corpuscules | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9783822B2 | Gene therapy methods | Chemistry; Metallurgy | 1 | Active |
| US10280435B2 | Gene therapy methods | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.